GLP-1 insurance coverage varies significantly depending on your insurance type, specific plan, medication, and whether it is prescribed for diabetes or weight management. Understanding your likely coverage status can help you plan for costs and explore alternatives before filling a prescription. Use this checker to see estimated coverage, copays, and tips for getting your GLP-1 medication covered.
Coverage Disclaimer
Coverage varies by specific plan. Contact your insurance for exact benefit details. This tool provides general guidance only and is not a guarantee of coverage. Updated March 2026.
Check Your Coverage
Coverage Assessment
Tips for Getting Coverage
Alternative Savings Options
Patient Assistance Programs
How to Use the GLP-1 Insurance Coverage Checker
Navigating GLP-1 insurance coverage can be confusing, with rules varying by plan type, medication, and whether your prescription is for diabetes or weight management. This checker helps you understand your likely coverage status so you can plan ahead and explore all available options for affording your medication.
Step 1: Select Your Insurance Type
Choose your insurance category from the dropdown. Options include Medicare Part D, Medicaid, employer-sponsored commercial plans, ACA Marketplace plans, Tricare, VA Healthcare, and no insurance. Each type has different rules for covering GLP-1 medications, and selecting the right one ensures accurate guidance.
Step 2: Choose Your Medication and Indication
Select the specific GLP-1 medication you are interested in — Ozempic, Wegovy, Mounjaro, or Zepbound — and whether it is prescribed for type 2 diabetes or weight management. Coverage often differs dramatically between these two indications. For example, most plans cover Ozempic for diabetes but fewer cover Wegovy for weight loss.
Step 3: Review Your Coverage Assessment
The results show your likely coverage status with a clear explanation of what to expect. You will see estimated monthly and annual costs compared to the full retail price. The coverage tips section provides actionable steps for getting coverage approved, including information about prior authorization requirements, step therapy protocols, and the appeals process.
Step 4: Explore Alternative Options
If your medication is not covered or costs are too high, the tool shows alternative savings options. These include manufacturer savings cards (as low as $25 per month for eligible patients), compounded versions at significantly lower prices, patient assistance programs for qualifying income levels, and the Medicare GENEROUS model for eligible beneficiaries starting April 2026.
Understanding Coverage Differences by Plan Type
Medicare Part D traditionally covers diabetes medications but is now expanding weight management coverage under the GENEROUS model. Medicaid coverage varies by state. About 40% of employer plans cover GLP-1s for weight loss, while most cover them for diabetes. Tricare covers both indications. Understanding these patterns helps you anticipate your coverage and prepare to advocate for approval if needed.
Next Steps After Checking Coverage
After reviewing your coverage assessment, contact your insurance provider to confirm exact benefits for your specific plan. Ask about prior authorization requirements, preferred pharmacies, and whether your plan offers a specialty pharmacy program. If coverage is denied, review the tips section for guidance on appealing the decision with your doctor's help.
FAQ
Is this GLP-1 insurance checker free?
Yes, this tool is completely free with no signup or account required. You can check coverage for as many insurance types and medications as you need. All data processing runs locally in your browser — nothing is stored or sent to any server.
Is my data safe and private?
Yes, all calculations run entirely in your browser. No insurance information, medication selections, income data, or personal details are sent to any server. Your data stays on your device only.
Does Medicare cover GLP-1 medications for weight loss?
Medicare Part D has traditionally covered GLP-1s only for type 2 diabetes. However, starting April 2026, the GENEROUS model is expanding weight management coverage for Wegovy and Zepbound with estimated copays of $35-50 per month. Contact your Part D plan for specific enrollment details.
What is prior authorization for GLP-1 medications?
Prior authorization means your insurance requires your doctor to get approval before they will cover the medication. This typically involves submitting documentation showing medical necessity, such as a diabetes diagnosis, BMI over 30, or failed attempts at diet and exercise. The process usually takes 3-7 business days.
Can I appeal if my insurance denies GLP-1 coverage?
Yes, you have the right to appeal any coverage denial. Your doctor can submit a letter of medical necessity explaining why the medication is appropriate for your condition. Many denials are overturned on appeal. Most insurers allow two levels of internal appeal plus an external review through your state insurance department.
What is step therapy for GLP-1 prescriptions?
Step therapy requires you to try lower-cost treatments first before your insurance will cover a more expensive GLP-1 medication. For example, your plan might require you to try metformin for diabetes or document a supervised weight-loss program before approving Ozempic or Wegovy. Your doctor can sometimes request an exception.
Are compounded GLP-1 medications covered by insurance?
Generally no. Most insurance plans do not cover compounded medications because they are not FDA-approved products. Compounded semaglutide and tirzepatide are typically cash-pay only, costing $149-449 per month depending on the compound pharmacy. However, this can still be cheaper than brand-name medications without insurance.
How accurate is this coverage information?
This tool provides general guidance based on typical coverage patterns as of 2026. Actual coverage varies significantly by specific plan, employer, state, and formulary. Always contact your insurance provider directly for exact benefit details before making treatment decisions.